Integris Health, a manufacturer of medical devices, has raised its initial funding from a group of well-known investors, which includes India SME Fund and Mukul Agarwal. Everstone Capital provides support to the business.

Through strategic acquisitions and internal product development initiatives, Integris Health said in a press release that the proceeds will be used for expansion into multiple therapeutic areas, including in-vitro diagnostics and laboratory solutions.

Probir Das was appointed CEO of the company in 2024 to oversee its expansion plans. The company has started IPO preparations and plans to list publicly by the end of 2025.

Integris Health is a medical device company that was founded in 2008 by Gurmit Singh Chugh and operates in the fields of vascular surgery therapy, cardiovascular medicine, and interventional cardiology. This fully integrated company has production facilities in Germany, the Netherlands, and India, sales presence in more than 50 markets, and an end-to-end presence in product development, manufacturing, sales, and distribution.

According to Integris Health, it has established strategic alliances with top medical facilities, academic institutions, international manufacturers of medical technology, and interventional cardiologists over the years.

It blends India's entrepreneurial culture and potent capacity for producing innovative goods at competitive prices with the best of German engineering, intellectual property, and high standards.

Integris Health seeks to strengthen the Indian medical technology device sector by utilising its state-of-the-art research and development, strategic alliances, strong distribution networks, and the low cost of manufacturing in India.